These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 8281362)
1. Cholesterol and coronary heart disease in women: an overview of primary and secondary prevention. Moreno GT; Manson JE Coron Artery Dis; 1993 Jul; 4(7):580-7. PubMed ID: 8281362 [No Abstract] [Full Text] [Related]
2. [Cholesterol: how and when to treat it?]. Masana MarĂn L Med Clin (Barc); 1985 Oct; 85(10):423-5. PubMed ID: 4079497 [No Abstract] [Full Text] [Related]
3. [Lipid therapy. Goal and use in prevention of coronary heart disease]. Windler E; Greten H Internist (Berl); 1996 Dec; 37(12):1244-8. PubMed ID: 9081925 [No Abstract] [Full Text] [Related]
4. Aggressive medical therapy for the prevention and treatment of coronary artery disease. Malloy MJ; Kane JP Dis Mon; 1998 Jan; 44(1):1-40. PubMed ID: 9457050 [No Abstract] [Full Text] [Related]
5. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. Downs JR; Clearfield M; Weis S; Whitney E; Shapiro DR; Beere PA; Langendorfer A; Stein EA; Kruyer W; Gotto AM JAMA; 1998 May; 279(20):1615-22. PubMed ID: 9613910 [TBL] [Abstract][Full Text] [Related]
6. What are the priorities for managing cholesterol effectively? Brown WV Am J Cardiol; 2001 Aug; 88(4A):21F-4F. PubMed ID: 11520483 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of rosuvastatin compared with other statins at selected starting doses in hypercholesterolemic patients and in special population groups. Blasetto JW; Stein EA; Brown WV; Chitra R; Raza A Am J Cardiol; 2003 Mar; 91(5A):3C-10C; discussion 10C. PubMed ID: 12646336 [TBL] [Abstract][Full Text] [Related]
8. The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study. Mikhailidis DP; Wierzbicki AS Curr Med Res Opin; 2002; 18(4):215-9. PubMed ID: 12201622 [No Abstract] [Full Text] [Related]
9. Lipid and apolipoprotein ratios: association with coronary artery disease and effects of rosuvastatin compared with atorvastatin, pravastatin, and simvastatin. Rader DJ; Davidson MH; Caplan RJ; Pears JS Am J Cardiol; 2003 Mar; 91(5A):20C-23C; discussion 23C-24C. PubMed ID: 12646340 [TBL] [Abstract][Full Text] [Related]
10. High blood cholesterol. National Heart, Lung and Blood Institute Nutr Clin Care; 2003; 6(3):108-14. PubMed ID: 14979453 [TBL] [Abstract][Full Text] [Related]
11. High-density lipoprotein cholesterol and triglycerides as therapeutic targets for preventing and treating coronary artery disease. Gotto AM Am Heart J; 2002 Dec; 144(6 Suppl):S33-42. PubMed ID: 12486414 [TBL] [Abstract][Full Text] [Related]
12. Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. Frick MH; Elo O; Haapa K; Heinonen OP; Heinsalmi P; Helo P; Huttunen JK; Kaitaniemi P; Koskinen P; Manninen V N Engl J Med; 1987 Nov; 317(20):1237-45. PubMed ID: 3313041 [TBL] [Abstract][Full Text] [Related]
13. Treatment of hypercholesterolemia in the elderly: is cholesterol a risk factor and should it be treated? Luepker RV; Mo JP Coron Artery Dis; 1993 Jul; 4(7):605-10. PubMed ID: 8281365 [No Abstract] [Full Text] [Related]
14. Treatment of hypercholesterolemia in patients with known coronary artery disease. Schlant RC Heart Dis Stroke; 1993; 2(5):373-6. PubMed ID: 8137037 [No Abstract] [Full Text] [Related]
15. [Prevention and treatment of coronary heart disease: lowering LDL, increasing HDL or monitoring both?]. Windler E Internist (Berl); 1996 Jun; 37(6):643-6. PubMed ID: 8768000 [No Abstract] [Full Text] [Related]
17. [Primary prevention in hypercholesterolemia. High HDL cholesterol levels and female gender underestimated protective factors]. Wahlberg G Lakartidningen; 2006 Jan 18-24; 103(3):131-4. PubMed ID: 16465756 [No Abstract] [Full Text] [Related]
18. Treatment with atorvastatin to the National Cholesterol Educational Program goal versus 'usual' care in secondary coronary heart disease prevention. The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study. Athyros VG; Papageorgiou AA; Mercouris BR; Athyrou VV; Symeonidis AN; Basayannis EO; Demitriadis DS; Kontopoulos AG Curr Med Res Opin; 2002; 18(4):220-8. PubMed ID: 12201623 [TBL] [Abstract][Full Text] [Related]
19. A summary of implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ; Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1329-30. PubMed ID: 15297284 [No Abstract] [Full Text] [Related]